| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 2 438-446, Copyright © 1993 by American Association of Immunologists
ARTICLES |
KL Rock, L Rothstein, S Gamble and C Fleischacker
Division of Lymphocyte Biology, Dana Farber Cancer Institute, Boston, MA 02115.
Exogenous Ag in the extracellular fluids do not gain access to the class I Ag-presenting pathway in most cells. However, there is an APC resident in spleen that can process and present exogenous Ag in association with class I molecules. We characterize the phenotype of this cell. This APC is of low buoyant density, is adherent to Sepharose and glass, and expresses both class II molecules and FcR. This phenotype identifies this APC as a macrophage. Resident, peptone- and thioglycolate-induced peritoneal macrophages also display this Ag- presenting activity. Analysis with CTL clones suggest that this Ag- presenting pathway may be active in only a subset of macrophages. A similar Ag-presenting activity is also present in dendritic cell- enriched populations from spleen although we cannot rule out the possible involvement of contaminating macrophages. In contrast, B and T cells that are resident in spleen and LPS blasts are unable to present exogenous Ag in association with class I molecules. The presentation of exogenous OVA with class I molecules is not inhibited by the inhibitors of thiol proteases, leupeptin, and antipain. The presence of gelonin, a ribosomal inactivating protein, in the extracellular fluids inhibits the ability of these APC to present exogenous OVA. Under identical conditions, gelonin does not inhibit Con A-stimulated T cell proliferation, or LPS-stimulated B cell proliferation and Ag presentation. These results are discussed in relation to the potential pathways through which an Ag in the extracellular fluids is presented with MHC class I molecules.
This article has been cited by other articles:
|
|
 |
|
  X.-S. He, T. H. Holmes, C. Zhang, K. Mahmood, G. W. Kemble, D. B. Lewis, C. L. Dekker, H. B. Greenberg, and A. M. Arvin Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines J. Virol., December 1, 2006; 80(23): 11756 - 11766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-A. M. Pozzi, J. W. Maciaszek, and K. L. Rock Both Dendritic Cells and Macrophages Can Stimulate Naive CD8 T Cells In Vivo to Proliferate, Develop Effector Function, and Differentiate into Memory Cells J. Immunol., August 15, 2005; 175(4): 2071 - 2081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Palena, M. Zhu, J. Schlom, and K.-Y. Tsang Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cells Blood, July 1, 2004; 104(1): 192 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Ackerman and P. Cresswell Regulation of MHC Class I Transport in Human Dendritic Cells and the Dendritic-Like Cell Line KG-1 J. Immunol., April 15, 2003; 170(8): 4178 - 4188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Manfras, S. Reuter, T. Wendland, and P. Kern Increased Activation and Oligoclonality of Peripheral CD8+ T Cells in the Chronic Human Helminth Infection Alveolar Echinococcosis Infect. Immun., March 1, 2002; 70(3): 1168 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kita, Z.-X. Lian, J. Van de Water, X.-S. He, S. Matsumura, M. Kaplan, V. Luketic, R. L. Coppel, A. A. Ansari, and M. E. Gershwin Identification of HLA-A2-restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis: T Cell Activation Is Augmented by Immune Complexes Cross-Presented by Dendritic Cells J. Exp. Med., January 7, 2002; 195(1): 113 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chen, K. F. Weis, Q. Chu, C. Erickson, R. Endres, C. R. Lively, J. Osorio, and L. G. Payne Epidermal Powder Immunization Induces both Cytotoxic T-Lymphocyte and Antibody Responses to Protein Antigens of Influenza and Hepatitis B Viruses J. Virol., December 1, 2001; 75(23): 11630 - 11640. [Abstract] [Full Text]
|
|
|
|
|
|
I. Popov, C. S. Dela Cruz, B. H. Barber, B. Chiu, and R. D. Inman The Effect of an Anti-HLA-B27 Immune Response on CTL Recognition of Chlamydia J. Immunol., September 15, 2001; 167(6): 3375 - 3382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Maecker, S. A. Ghanekar, M. A. Suni, X.-S. He, L. J. Picker, and V. C. Maino Factors Affecting the Efficiency of CD8+ T Cell Cross-Priming with Exogenous Antigens J. Immunol., June 15, 2001; 166(12): 7268 - 7275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Rudolf, S. C. Fausch, D. M. Da Silva, and W. M. Kast Human Dendritic Cells Are Activated by Chimeric Human Papillomavirus Type-16 Virus-Like Particles and Induce Epitope-Specific Human T Cell Responses In Vitro J. Immunol., May 15, 2001; 166(10): 5917 - 5924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott The Potent Adjuvant Activity of Archaeosomes Correlates to the Recruitment and Activation of Macrophages and Dendritic Cells In Vivo J. Immunol., February 1, 2001; 166(3): 1885 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M.M. den Haan, S. M. Lehar, and M. J. Bevan Cd8+ but Not Cd8- Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo J. Exp. Med., December 18, 2000; 192(12): 1685 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Haicheur, E. Bismuth, S. Bosset, O. Adotevi, G. Warnier, V. Lacabanne, A. Regnault, C. Desaymard, S. Amigorena, P. Ricciardi-Castagnoli, et al. The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens J. Immunol., September 15, 2000; 165(6): 3301 - 3308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Peppelenbosch, M. DeSmedt, G. Pynaert, S. J. H. van Deventer, and J. Grooten Macrophages Present Pinocytosed Exogenous Antigen Via MHC Class I Whereas Antigen Ingested by Receptor-Mediated Endocytosis Is Presented Via MHC Class II J. Immunol., August 15, 2000; 165(4): 1984 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Almand, J. R. Resser, B. Lindman, S. Nadaf, J. I. Clark, E. D. Kwon, D. P. Carbone, and D. I. Gabrilovich Clinical Significance of Defective Dendritic Cell Differentiation in Cancer Clin. Cancer Res., May 1, 2000; 6(5): 1755 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Vabulas, H. Pircher, G. B. Lipford, H. Hacker, and H. Wagner CpG-DNA Activates In Vivo T Cell Epitope Presenting Dendritic Cells to Trigger Protective Antiviral Cytotoxic T Cell Responses J. Immunol., March 1, 2000; 164(5): 2372 - 2378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Muerkoster, M. Rocha, P. R. Crocker, V. Schirrmacher, and V. Umansky Sialoadhesin-Positive Host Macrophages Play an Essential Role in Graft-Versus-Leukemia Reactivity in Mice Blood, June 15, 1999; 93(12): 4375 - 4386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Maitre, J. M. Brown, M. Demcheva, J. R. Kelley, M. A. Lockett, J. Vournakis, and D. J. Cole Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination Clin. Cancer Res., May 1, 1999; 5(5): 1173 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Liebana, R. M. Girvin, M. Welsh, S. D. Neill, and J. M. Pollock Generation of CD8+ T-Cell Responses to Mycobacterium bovis and Mycobacterial Antigen in Experimental Bovine Tuberculosis Infect. Immun., March 1, 1999; 67(3): 1034 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Foon, J. Yannelli, and M. Bhattacharya-Chatterjee Colorectal Cancer as a Model for Immunotherapy Clin. Cancer Res., February 1, 1999; 5(2): 225 - 236. [Full Text] [PDF]
|
|
|
|
|
|
H. T. Maecker, D. T. Umetsu, R. H. DeKruyff, and S. Levy Cytotoxic T Cell Responses to DNA Vaccination: Dependence on Antigen Presentation via Class II MHC J. Immunol., December 15, 1998; 161(12): 6532 - 6536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mark Tompkins, J. R. Kraft, C. T. Dao, M. J. Soloski, and P. E. Jensen Transporters Associated with Antigen Processing (TAP)-independent Presentation of Soluble Insulin to {alpha}/{beta} T Cells by the Class Ib Gene Product, Qa-1b J. Exp. Med., September 7, 1998; 188(5): 961 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vallee, J.-M. Guillaumin, G. Thibault, Y. Gruel, Y. Lebranchu, P. Bardos, and H. Watier Human T Lymphocyte Proliferative Response to Resting Porcine Endothelial Cells Results from an HLA-Restricted, IL-10-Sensitive, Indirect Presentation Pathway But Also Depends on Endothelial-Specific Costimulatory Factors J. Immunol., August 15, 1998; 161(4): 1652 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Heath, C. Kurts, J. F.A.P. Miller, and F. R. Carbone Cross-tolerance: A Pathway for Inducing Tolerance to Peripheral Tissue Antigens J. Exp. Med., May 18, 1998; 187(10): 1549 - 1553. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Osanto Vaccine Trials for the Clinician: Prospects for Tumor Antigens Oncologist, October 1, 1997; 2(5): 284 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hoek, J. Schoemaker, and H. A. Drexhage Premature Ovarian Failure and Ovarian Autoimmunity Endocr. Rev., February 1, 1997; 18(1): 107 - 134. [Abstract] [Full Text]
|
|
|
|
 |
|
 R Suto and P. Srivastava A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides Science, September 15, 1995; 269(5230): 1585 - 1588. [Abstract] [PDF]
|
|
|
|
|
|
A. Huang, P Golumbek, M Ahmadzadeh, E Jaffee, D Pardoll, and H Levitsky Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens Science, May 13, 1994; 264(5161): 961 - 965. [Abstract] [PDF]
|
|
|
|
 |
|
 T Lang, C de Chastellier, C Frehel, R Hellio, P Metezeau, S. Leao, and J. Antoine Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis J. Cell Sci., January 1, 1994; 107(1): 69 - 82. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
